Abstract
Considerable advances in biomedical research during the last 20 years have led to an increased interest in human tumor-associated antigens as potential targets for the diagnosis and therapy of cancer. Research efforts in this area have intensified during the last decade because of the availability of monoclonal antibodies and the rapid emergence of increasingly sophisticated technologies of gene cloning. The relatively slow progress in the clinical treatment of solid tumors has provided further impetus to increased efforts to render immunological approaches useful for cancer therapy, particularly by applying immunoconjugates. Among these conjugates, those made between monoclonal antibodies and either chemotherapeutic drugs, radionuclides, or plant toxins represent the three major categories.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bumol TF, Wang OC, Reisfeld RA, Kaplan NO (1983) Monoclonal antibody and an anti- body-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growth. Proc Natl Acad Sci USA 80: 529–533
Cheresh DA (1987) Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA 84: 6471–6475
Durand RE, Olive PL (1981) Flow cytometry studies of intracellular adriamycin in single cells in vitro. Cancer Res 41: 3489–3494
Ehrlich P (1906) In: Collected studies on immunity, vol I I. John Wiley, New York
Ghose T, Guclu A, Tai J (1975) Suppression of an AKR lymphoma by antibody and chloram-bucil. J Nat Cancer Inst 55: 1353–1357
Ghose T, Norvell ST, Guclu A, Bodurtha A, MacDonald AS (1977) Immunochemotherapy of malignant melanoma with chlorambucil-bound antimelanoma globulins: Preliminary results on patients with disseminated disease. J Nat Cancer Inst 58: 845–852
Herlyn AM, Steplewski Z, Herlyn MF, Koprowski H (1980) Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Cancer Res 40: 717–721
Hurwitz E, Levy R, Maron R, Wilcheck M, Arnon R, Sela M (1975) The covalent binding of daunomycin and adriamycin to antibodies with retention of both drug and antibody activities. Cancer Res 35: 1175–1181
Mathe G, Loc TB, Bernard J (1958) Effet sur la Leucémie 1210 de la souris d’une combinaison par diazotation d’A-methopterine et de γ-globulins de hamsters porteurs de celle leucémie par hétérogreffe. CR Acad Sci Paris 246: 1626–1628
Oldham RK, Foon KA, Morgan AC, Woodhouse GA, Schroff RW, Abrams PG, Feer MF, Farrell MM, Kinball ES, Sherwin SA (1984) Monoclonal antibody therapy of malignant melanoma: In vivo localization in cutaneous metastasis after intravenous administration. J Clin Oncol 2: 1235–1244
Pastan I, Willingham MC (1983) Receptor-mediated endocytosis-coated pits, receptosomes and the Golgi. Trend Briochem Sci 8: 250–254
Pietersz G A, Kanellos J, Smyth M J, Zalcberg J, McKenzie LFC (1987) The use of monoclonal antibody conjugates for the diagnosis and treatment of cancer. Immunol and Cell Biol 65: 111–125
Sivam GP, Comezoglu T, Jarvis BB, Morgan AC (1988) Immunoconjugates of ribosomal inhibiting drugs and monoclonal antibody. Abstract 34, meeting on immunoconjugates, San Diego, California 4–6 Feb 1988
Yang HM, Reisfeld RA (1988) Doxorubicin conjugated with a monoclonal antibody to a human melanoma-associated proteoglycan suppresses the growth of established term on xeno-grafts in nude mice. Proc Natl Acad Sci USA 85: 1189–1193
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Reisfeld, R.A., Muller, B., Yang, HM. (1989). Immunochemotherapy of Cancer: A Perspective. In: Beger, H.G., Büchler, M., Reisfeld, R.A., Schulz, G. (eds) Cancer Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73721-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-73721-3_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73723-7
Online ISBN: 978-3-642-73721-3
eBook Packages: Springer Book Archive